Antiphospholipid Syndrome: Not All Antibodies Are Created Equal
Nicola Pozzi, Associate Professor of Thrombosis and Hemostasis and Autoimmunity at Saint Louis University School of Medicine, shared a post on LinkedIn:
”Antiphospholipid Syndrome (APS) isn’t a one-size-fits-all disease—and neither are antiphospholipid antibodies.
In our latest work, led by Suresh Kumar, we advance understanding of the molecular complexity behind pathogenic antibodies targeting β2GPI and, in doing so, we introduce new concepts and tools that may help achieve more personalized diagnostic strategies and accelerate the development of neutralization approaches.
Our goal of building an Antiphospholipid Antibody Atlas to fight APS continues… Just keep watching APS…Just keep watching…”
For more information
Find More Posts on Hemostasis Today.
-
Jan 17, 2026, 05:05Dr Abdul Mannan: Iron Deficiency Can Hide Beta-Thalassaemia Trait
-
Jan 17, 2026, 05:01Fortis Memorial Research Institute, Gurugram Ranked Among the World’s Top 50 Smart Hospitals
-
Jan 17, 2026, 04:59Flora Peyvandi: Factor VIII in Vitro Bioequivalence of Mim8 Haemostatic Effect
-
Jan 17, 2026, 04:58Desmopressin in Bleeding Disorders: 5,000 Views in 6 Months – Why This Topic Matters
-
Jan 17, 2026, 04:58Sifat Jubaira Shares Chylous Blood Clinical Case: Milky Blood Instead of Red
-
Jan 17, 2026, 04:57Automated VWF Multimer Analysis Using Deep Learning for Improved Diagnosis and Classification of vWD
-
Jan 17, 2026, 04:55Trends in Catheter-Directed Therapy and In-Hospital Outcomes in Acute PE
-
Jan 17, 2026, 04:54Antithrombin III Deficiency – Explained by Astha Thakkar
-
Jan 17, 2026, 04:53FDA Approval of Mitapivat: Redefining Thalassemia Management